Pharmaceuticals, Biotechnology and Life Sciences
Designation grants access to enter the Innovative Licensing and Access Pathway (ILAP) Five patients treated with FBX-101 show positive safety…
> Life Sciences Review annually selects 10 preeminent CROs and has chosen Melior Discovery as the top CRO in 2023…
Following expansion of its generic injectables portfolio in September 2023, Meitheal is preparing to launch up to 20 new products…
Proceeds to Support Advancement of Engrail’s Pipeline for Neuropsychiatric and Neurodevelopmental Disorders SAN DIEGO–(BUSINESS WIRE)–Engrail Therapeutics™ (Engrail) (the Company), a…
BOSTON & SAN DIEGO–(BUSINESS WIRE)–Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance…
Trial met the primary efficacy endpoint demonstrating non-inferiority of the incidence of acute kidney injury for INTERCEPT Red Blood Cells…
SEATTLE–(BUSINESS WIRE)–Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing…
HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) today announced that it has achieved…
Second biotechnology company to potentially out-license novel compounds from Enveric’s portfolio of assets with possible significant milestone payments and royalties…
Versavo® (bevacizumab) is indicated for the treatment of several types of cancers including metastatic colorectal cancer, advanced non-squamous non-small cell…